Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06338865 · ClinicalTrials.gov registry record · NA

Short Title: Standard vs. Lower Pressure Pneumoperitoneum

A NA study of Laparoscopic Surgery, sponsored by Cedars-Sinai Medical Center.

Recruiting
Registry status
NA
Development phase
294
Enrollment target
1
Study location

NCT06338865: Recruiting NA study of Laparoscopic Surgery, sponsored by Cedars-Sinai Medical Center.

NCT06338865 is a NA study of Laparoscopic Surgery that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 294 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06338865, a NA study of Laparoscopic Surgery, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.

RECRUITING
Registry status
NA
Development phase
294 participants
Enrollment target
1
Study location

Study Summary

This study aims to investigate the effect of varying insufflation pressures on post-operative pain and adequacy of surgical field visualization among patients undergoing laparoscopic surgery with a minimally invasive gynecologic surgeon.

Primary Outcome

The numerical rating scale is a pain screening tool that is routinely used to assess pain severity in the postoperative setting using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."

Conditions Studied

Interventions

  • DRUG Bupivacaine
  • DRUG Oxycodone
  • OTHER Carbon dioxide

Study Locations (1)

California

  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 294 participants
Start Date 2024-05-03
Est. Completion 2027-04
Phase NA
Cedars-Sinai Medical Center

339 total trials

What NCT06338865 shows while recruiting

NCT06338865 is an interventional study that assigns participants to a tested intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Laparoscopic Surgery appearing as the primary indexed condition, and to 3 interventions - of which Bupivacaine is the first listed.

NCT06338865 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06338865 about?

NCT06338865 is a clinical study titled "Short Title: Standard vs. Lower Pressure Pneumoperitoneum". This study aims to investigate the effect of varying insufflation pressures on post-operative pain and adequacy of surgical field visualization among patients undergoing laparoscopic surgery with a minimally invasive gynecologic surgeon.

What is the current status of trial NCT06338865?

This trial is currently recruiting. It is a NA study. The enrollment target is 294 participants. The study started on 2024-05-03. Estimated completion is 2027-04.

What conditions does trial NCT06338865 study?

This clinical trial studies the following conditions: Laparoscopic Surgery.

What interventions are being tested in trial NCT06338865?

The interventions under investigation include: Bupivacaine (DRUG), Oxycodone (DRUG), Carbon dioxide (OTHER).

Who is sponsoring clinical trial NCT06338865?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06338865 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Laparoscopic Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06338865's enrollment target sits among peer trials

294 373rd of 2000 higher than 1,626 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05775159 · 294 participants · Phase 2

    Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

  • NCT06262113 · 294 participants · NA

    A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

  • NCT06395467 · 294 participants · NA

    Integrated Treatment for Enhancing Growth in Recovery During Adolescence

  • NCT06574009 · 294 participants · Phase 4

    Better Options for Chronic Cancer Pain

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06338865, the US trial registry maintained by the National Library of Medicine. NCT06338865 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.